(IBTM) iShares iBonds Dec 2032 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E2963

US Treasury Securities, Government Bonds, Fixed Income

Description: IBTM iShares iBonds Dec 2032

The iShares iBonds Dec2032 Term Treasury ETF (NASDAQ:IBTM) is a target maturity ETF that tracks a market value-weighted index of U.S. Treasury securities, with a focus on securities that will mature in December 2032. The index is constructed by reducing the amounts outstanding by the amounts held by the Federal Reserve SOMA, providing a more accurate representation of the available market.

The funds investment strategy is to invest at least 80% of its assets in the component securities of the index, and at least 90% of its assets in U.S. Treasury securities that are expected to help the fund track the index. This approach is designed to provide a high degree of tracking accuracy, except during the final months of the funds operations.

From a performance perspective, key metrics to consider include the funds yield, duration, and credit quality. Given the funds focus on U.S. Treasury securities, credit quality is likely to be extremely high. The funds duration is likely to be closely matched to the maturity date of December 2032, providing a clear indication of the funds interest rate risk. Investors should also consider the funds expense ratio, which is likely to be relatively low given the funds passive management strategy.

In terms of key performance indicators (KPIs), investors may want to monitor the funds tracking error, yield to maturity, and average duration. A low tracking error would indicate that the fund is effectively replicating the performance of the underlying index. The yield to maturity would provide a clear indication of the funds expected return, while the average duration would provide insight into the funds sensitivity to changes in interest rates.

IBTM ETF Overview

Market Cap in USD 464m
Category Target Maturity
TER 0.07%
IPO / Inception 2022-07-06

IBTM ETF Ratings

Growth Rating 60.2%
Fundamental -
Dividend Rating 67.2%
Return 12m vs S&P 500 -8.69%
Analyst Rating -

IBTM Dividends

Dividend Yield 12m 3.81%
Yield on Cost 5y 4.07%
Annual Growth 5y 66.26%
Payout Consistency 100.0%
Payout Ratio %

IBTM Growth Ratios

Growth Correlation 3m 86.3%
Growth Correlation 12m 91.8%
Growth Correlation 5y 58.2%
CAGR 5y 5.26%
CAGR/Max DD 3y (Calmar Ratio) 0.51
CAGR/Mean DD 3y (Pain Ratio) 1.83
Sharpe Ratio 12m -0.37
Alpha -13.31
Beta 1.150
Volatility 4.71%
Current Volume 73.1k
Average Volume 20d 100k
Stop Loss 22.6 (-3.2%)
Signal 0.44

What is the price of IBTM shares?

As of October 22, 2025, the stock is trading at USD 23.34 with a total of 73,103 shares traded.
Over the past week, the price has changed by +0.45%, over one month by +1.14%, over three months by +3.31% and over the past year by +6.31%.

Is iShares iBonds Dec 2032 a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds Dec 2032 (NASDAQ:IBTM) is currently (October 2025) a good stock to buy. It has a ValueRay Growth Rating of 60.22 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTM is around 22.49 USD . This means that IBTM is currently overvalued and has a potential downside of -3.64%.

Is IBTM a buy, sell or hold?

iShares iBonds Dec 2032 has no consensus analysts rating.

What are the forecasts/targets for the IBTM price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.5 9.1%

Last update: 2025-10-20 03:54

IBTM Fundamental Data Overview

Market Cap USD = 463.5m (463.5m USD * 1.0 USD.USD)
Beta = 1.15
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 463.5m USD (463.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 463.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 463.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.25% (E(463.5m)/V(463.5m) * Re(10.25%) + (debt-free company))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBTM ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle